Posters

The effect of placement of intraoperative Mitomycin C on intraocular pressure control with the InnFocus MicroShunt™

Poster Details

First Author: I.Riss FRANCE

Co Author(s):    J. Battle   L. Pinchuk   Y. Kato   B. Weber   J. Parel        

Abstract Details

Purpose:

To compare intraocular pressure (IOP) at one, two and three years with the InnFocus MicroShunt® with or without cataract surgery with different placement and concentration of Mitomycin C (MMC).

Setting:

Clinique Mutualiste de Pessac, 33600 ,France

Methods:

A retrospective study in two centers (France and Dominican Republic) and two surgeons. Eighty seven adults with POAG requiring filtering surgery. One MicroShunt was placed in one eye of each patient. The effect of concentration and site of application of MMC was assessed by IOP and medication reduction at one, two and three years.

Results:

Twenty-three eyes treated with 0,4 mg/mL MMC near the limbus have 55% IOP drop : 23,8 ± 5,3 to 10,7 ± 2,8 mmHg at one year (54% at 3 years). Medication drop is 87%. Thirty-one eyes treated with 0,2 mg/mL MMC near the limbus have 52% IOP drop : 27,9 ± 6,7 to 13,3 ± 3,3 mmHg at one year. Medication reduction is 88%. Thirty-three eyes treated with 0,4 mg/mL MMC deep in the pocket have 38% IOP drop : 25,4 ± 7,9 to 15,7 ± 4,6 mmHg at one year. Medication drop is 72%. With no serious adverse events

Conclusions:

The InnFocus MicroShunt® is a safe filtering surgery and the efficacy is related to the location of application of MMC.

Financial Disclosure:

One or more of the authors gains financially from product or procedure presented, One or more of the authors travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, One or more of the authors research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, One or more of the authors receives non-monetary benefits from a company producing, developing or supplying the product or procedure presented., One or more of the authors receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, One or more of the authors is employed by a for-profit company with an interest in the subject of the presentation, One or more of the authors has significant investment interest in a company producing, developing or supplying product or procedure presented